Skip to main content
Marshall Slade Baker
( out of 965 reviews )

Marshall Slade Baker, MD, MBA

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

Clinic 3A, Gastrointestinal
1950 Circle of Hope
Salt Lake City , UT 84112

Marshall Baker, MD is a surgeon-scientist with over 24 years of expertise in benign and malignant disease of the pancreas, liver, gallbladder, and bile ducts. His current clinical focus is on complex foregut oncology and hepatobiliary surgery. He recognizes that minimally invasive robotic and laparoscopic surgeries generally improve recovery and utilizes these approaches with pancreas and biliary malignancy whenever possible.

Dr. Baker’s clinical specialties Include:

  • Bile duct cancer (Cholangiocarcinoma)
  • Colorectal metastases
  • Cystic pancreatic tumors
  • Gallbladder cancer
  • Liver cancer
  • Neuroendocrine tumor of the pancreas
  • Pancreas cancer
  • Robotic liver and pancreas resection
  • Minimally invasive surgery (robotic & laparoscopic)

Dr. Baker has had a life-long passion for education and is currently a professor of surgery in the Department of Surgery at University of Utah Health, Spencer Fox Eccles School of Medicine, and serves as the Director of Surgical Simulation and the Associate Clerkship Director. His research lab continues to refine concepts of best practice in oncology using informatics-based comparative effectiveness study.

Dr. Baker earned his undergraduate degree from Duke University and medical degree from Dartmouth Medical School. He completed general surgery residency at Northwestern University. While at Northwestern, he pursued a three-year post-doctoral research fellowship in transplant immunology and obtained a master’s degree in business administration with a focus on health industry management and finance from the Kellogg School of Business. Following residency, he completed a clinical fellowship in advanced hepatopancreaticobiliary surgery at Indiana University Medical School.

Dr. Baker started his clinical practice and academic career in Chicago. He served sequentially on the faculties of Northwestern University Feinberg School of Medicine, the University of Chicago Pritzker School of Medicine, and Loyola University of Chicago Stritch School of Medicine where he was promoted to full professor. During these years, he developed and was recognized for clinical expertise in minimally invasive laparoscopic and robotic approaches to foregut oncology. He had a productive clinical research lab which employed advanced analytics to evaluate clinical outcomes and cost effectiveness for different treatment approaches to foregut malignancy.

Patient Rating

Patients consistently describe Dr. Baker and his team as highly knowledgeable, thorough, and professional. Reviewers highlight clear, honest explanations and attentive listening that helped them feel heard, reassured, and confident about treatment and surgery plans. Many also praise the team's responsiveness, compassion, and calm, organized approach throughout consultations and procedures.

Generated via Patient Reviews

4.9 /5
( out of 965 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


May 29, 2026
HUNTSMAN CANCER CENTER

very good

May 24, 2026
HUNTSMAN CANCER CENTER

I have been pleased with the service I have received. [TRANSLATED]

May 23, 2026
HUNTSMAN CANCER CENTER

Dr. Baker is easy to converse with and cares for my wellbeing.

May 21, 2026
HUNTSMAN CANCER CENTER

A kind and professional doctor. I would recommend him to anyone.

May 17, 2026
HUNTSMAN CANCER CENTER

He's my real life hero . His kindness and thoroughness are beyond comparison to any experience I've had before. I absolutely owe him my life and feel I gained a wonderful friendship

May 16, 2026
HUNTSMAN CANCER CENTER

Both doctor bakers have given me outstanding care overall care at the U is great

May 09, 2026
HUNTSMAN CANCER CENTER

Drm Baker is a very knowledgeable, kind and compassionate provider.

May 07, 2026
HUNTSMAN CANCER CENTER

Dr. Baker is very knowledgeable and explained things to where I could understand. He listen to me and made a plan to move forward.

May 02, 2026
HUNTSMAN CANCER CENTER

Just meet in virtual. But really seems to know what he is talking about. Can't wait to meet in person

May 01, 2026
HUNTSMAN CANCER CENTER

Dr. Baker is deeply committed to his patients and an excellent communicator. I will put my life in his hands every day

Apr 28, 2026
HUNTSMAN CANCER CENTER

Dr Baker is very personable--explained the medical situation and prognosis very well.

Apr 23, 2026
HUNTSMAN CANCER CENTER

Very skilled, very professional, very attentive.

Apr 09, 2026
HUNTSMAN CANCER CENTER

Excellent Dr. Highly recommend

Apr 01, 2026
HUNTSMAN CANCER CENTER

Very knowledgeable and helpful

Mar 26, 2026
HUNTSMAN CANCER CENTER

Highly recommend

Mar 20, 2026
HUNTSMAN CANCER CENTER

Dr Baker and his team were fabulous. They were decisive, made me feel safe, were knowledgeable about my particular situation and listened to each of my questions and took their time to provide answers. It was a great experience.

Mar 20, 2026
HUNTSMAN CANCER CENTER

We are glad we had Dr Baker for my husbands surgery. He has the best bed side manner for a surgeon! He was very kind and listened to concerns and to answer our questions as they arose. There was never a condescending vibe that sometimes we have had from other doctors. Just had a sincere demeanor to help us through this procedure. Would recommend to anyone who needs an oncology surgeon.

Mar 18, 2026
HUNTSMAN CANCER CENTER

Dr. Baker Explained the medical problem and medical procedures that needed to be taken to hopefully would help resolve and fix the problem; and dealt with the time line for recovery and healing.

Mar 18, 2026
HUNTSMAN CANCER CENTER

Dr Baker was outstanding. Explains things really well. Was always checking on me during my long stay.

Mar 17, 2026
HUNTSMAN CANCER CENTER

Amazing surgeon and overall provider. Highly recommend. Has performed two surgeries for me

Mar 04, 2026
HUNTSMAN CANCER CENTER

Dr. Baker is a strait shooter. He tells you what you need to hear in order to know what will await you should you folllow his recommendations.

Feb 28, 2026
HUNTSMAN CANCER CENTER

DR Baker was fantastic. Explained my questions in a way I could understand. Very caring on my surgery and recovery.

Feb 26, 2026
HUNTSMAN CANCER CENTER

He is very good at explaining what needs to be done

Feb 26, 2026
HUNTSMAN CANCER CENTER

Dr Baker has shown great care and concern about my welfare. I feel blessed to have him as my surgeon

Feb 15, 2026
HUNTSMAN CANCER CENTER

Dr. Baker is at the top of his profession, yet still unassuming & very caring.

Feb 04, 2026
HUNTSMAN CANCER CENTER

He is very professional and also very supportive and kind.

Jan 26, 2026
HUNTSMAN CANCER CENTER

He is wonderful. Explained everything well. Great bedside manners . I felt very at ease with him and trusting. I just hope I never have to do this again!! What a journey for sure.

Jan 24, 2026
HUNTSMAN CANCER CENTER

Dr Baker is an amazing surgeon that cares about his patients, he is kind, professional and he listened to me and explained my situation so that I understood what was going on. His kindness made everything less scary ~ thank you!

Jan 14, 2026
HUNTSMAN CANCER CENTER

Dr. Baker covered all the bases - rsulting in my full trust in his abilities and knowledge of my issues.

Dec 30, 2025
HUNTSMAN CANCER CENTER

Dr Baker is good surgery and explains everything does

Dec 27, 2025
HUNTSMAN CANCER CENTER

He is the best.

Dec 25, 2025
HUNTSMAN CANCER CENTER

Dr. Baker could--quite literally--not do a single thing any better than he did. He was absolutely perfect.

Dec 19, 2025
HUNTSMAN CANCER CENTER

Dr. Baker is extremely proficient, and caring and concerned in a personal way. We could not be more pleased with the outcome of the surgery and the follow-up care.

Dec 17, 2025
HUNTSMAN CANCER CENTER

The doctor show care and asks questions. Listens to what I have to say. I appreciate that he didn't rush into a decision for surgery until it was obvious something needs to be done.

Nov 26, 2025
HUNTSMAN CANCER CENTER

Driving down from Idaho was the right move, I'm very happy with Dr Baker

Nov 20, 2025
HUNTSMAN CANCER CENTER

Dr. Baker is smart, wonderful and kind. I am so grateful to have him as my doctor during this difficult time.

Nov 19, 2025
HUNTSMAN CANCER CENTER

I felt heard and I felt Dr. Baker saw me as a person and not just another patient. He made me feel comfortable talking to him and we are coming up with a plan to get me healthy again.

Nov 16, 2025
HUNTSMAN CANCER CENTER

He is the best ¿..

Nov 08, 2025
HUNTSMAN CANCER CENTER

Dr. Baker is the best!

Nov 07, 2025
HUNTSMAN CANCER CENTER

Excellent Dr. very fortunate to have him on my team

Nov 06, 2025
HUNTSMAN CANCER CENTER

Dr. Baker is the best as well the whole operation team.

Nov 02, 2025
HUNTSMAN CANCER CENTER

Honest & caring.

Oct 28, 2025
HUNTSMAN CANCER CENTER

Dr Baker is very caring and concerned about my well-being. He answers questions in terms that I can understand. His bedside manner is great.

Oct 25, 2025
HUNTSMAN CANCER CENTER

If you need a liver Dr. Dr Baker is the one.

Oct 22, 2025
HUNTSMAN CANCER CENTER

Dr. Baker is a 20 on a scale of 1-10. He is extremely proficient, and has genuine interest and concern for my needs. I give him the highest recommendation possible.

Oct 22, 2025
HUNTSMAN CANCER CENTER

DR Baker is concerned about my health and recommended surgery that will be in my best interests. He explained the procedure so it was family-friendly.

Oct 22, 2025
HUNTSMAN CANCER CENTER

Dr. Baker was outstanding! Professional, he had patience with me. He was pleasant and very clear about my MRI results. I am glad to have Dr. Baker as my doctor.

Oct 17, 2025
HUNTSMAN CANCER CENTER

So far so amazing, looking forward to the pre-op and surgery with him I know that I made the right choice. So grateful for all

Oct 10, 2025
HUNTSMAN CANCER CENTER

Dr. Baker is absolutely a 15 on a scale of 1-10. He has my total confidence as a surgeon and practitioner. I would recommend him in a heartbeat to anyone with a pancreatic issue.

Oct 03, 2025
HUNTSMAN CANCER CENTER

A great dr.like talking to him

Oct 01, 2025
HUNTSMAN CANCER CENTER

Pleasant and kind

Sep 30, 2025
HUNTSMAN CANCER CENTER

Dr. Baker is a caring and extremely knowledgeable doctor. He answered all my questions and brought a feel of calmness to myself and my family during this time of turmoil

Sep 17, 2025
HUNTSMAN CANCER CENTER

Dr Baker is excellent. His level of knowledge, skill and experience together with his kind personality helped me feel confident and calm going into surgery and recovery.

Aug 23, 2025
HUNTSMAN CANCER CENTER

Dr. Baker is an excellent doctor. Explains the procedure and what to expect after the procedure. He is a very competent and caring physician. I highly recommend him and his staff. Im very impressed with him and will return to him for care if need be.

Aug 22, 2025
HUNTSMAN CANCER CENTER

Very impressed with Dr. Baker's knowledge, professionalism and "bedside manner." I trust him implicitly.

Aug 06, 2025
HUNTSMAN CANCER CENTER

Dr. Baker is a brilliant surgeon, a compassionate physician, and a caring and thoughtful provider. I am deeply grateful for his care.

Jul 12, 2025
HUNTSMAN CANCER CENTER

Very informative. patient. Treated me like he had lots of time for me, my questions, and my well being.

Jul 11, 2025
HUNTSMAN CANCER CENTER

Dr. Baker was professional, exceptionally kind and caring, thorough and thoughtful. He listened attentively and explained things clearly. He is everything I believe a medical provider should be.

Jul 03, 2025
HUNTSMAN CANCER CENTER

Dr. Baker is incredibly skilled, wastes no energy, and communicates complicated matters exceptionally well.

May 30, 2025
HUNTSMAN CANCER CENTER

Dr Baker is a fantastic surgeon with a great sense of humor. I feel very fortunate to have him as a member of my care team.

May 30, 2025
HUNTSMAN CANCER CENTER

Dr Baker was reassuring to my liver issue and told me to seek further assistance if I need to

May 30, 2025
HUNTSMAN CANCER CENTER

An excellent, caring physician and surgeon!

May 23, 2025
HUNTSMAN CANCER CENTER

I would recommend anyone needing help such as I do would be very, very lucky to have him as their doctor.

May 13, 2025
HUNTSMAN CANCER CENTER

I would recommend him at any time he made me feel safe, cared about and not just a patient but a person. He made me feel like I would be cared for physically and emotionally thru this whole experience. He has made me feel like he was going to be there to see this thru to the end and he isnÕt going to leave me on my own

May 10, 2025
HUNTSMAN CANCER CENTER

Dr Marshall Baker is an answer to my prayers. His presence is so reassuring. He made sure I understood why all my doctors felt that my situation is complicated and why it was so important for me to be admitted to the hospital. Anyone who has the wonderful luck to have him for a doctor is lucky. Thank you so much Dr Baker.

May 08, 2025
HUNTSMAN CANCER CENTER

He cares.

May 07, 2025
HUNTSMAN CANCER CENTER

Honest and very through. Answered all my questions and was very helpful. Could not have asked for a better surgeon.

Apr 19, 2025
HUNTSMAN CANCER CENTER

Many thanks to you and the team that took care of me while at the hospital, and the information given to me, thanks for your time and kindness to you all

Apr 10, 2025
HUNTSMAN CANCER CENTER

Explained everything thoroughly very friendly and honest I like those qualities

Apr 03, 2025
HUNTSMAN CANCER CENTER

Offers great suggestions.

Mar 27, 2025
HUNTSMAN CANCER CENTER

This Dr. Baker was great.he explained everything in detail and answered my questions that I asked .I told him that he made my day with his answerers.

Feb 24, 2025
HUNTSMAN CANCER CENTER

Dr. Baker was amazing! I very much appreciated his personal approach.

Jan 17, 2025
HUNTSMAN CANCER CENTER

You will never regret choosing this amazing doctor. Kind and thorough. He will do everything he can to get you well. He listens to your concerns and addresses them. I really loved all his staff.

Jan 09, 2025
HUNTSMAN CANCER CENTER

He is the best

Jan 08, 2025
HUNTSMAN CANCER CENTER

Dr. Marshall is an amazing dr. He is caring and explained everything that I could understand. I high

Dec 27, 2024
HUNTSMAN CANCER CENTER

easy to work with

Dec 18, 2024
HUNTSMAN CANCER CENTER

Friendly and perfessional

Dec 11, 2024
HUNTSMAN CANCER CENTER

He answered my questions so I could understand. He was always honest on what to expect with regards to surgery, recovering time any long term effects. He was very caring and respectful to my needs and concerns.

Nov 29, 2024
HUNTSMAN CANCER CENTER

Absolutely wonderful doctor! Caring, skilled, personable.

Nov 22, 2024
HUNTSMAN CANCER CENTER

You will be in good hands with Dr Baker

Nov 12, 2024
HUNTSMAN CANCER CENTER

Excellent doctor

Nov 09, 2024
HUNTSMAN CANCER CENTER

Dr. Baker was very helpful in explaining my options which allowed me to make my decision. He is very courteous and paid attention to the patient needs

Nov 09, 2024
HUNTSMAN CANCER CENTER

Understanding the real issues. And creating options

Nov 07, 2024
HUNTSMAN CANCER CENTER

Da una atención muy buena

Oct 29, 2024
HUNTSMAN CANCER CENTER

I was very impressed with his professionalism and mannerism. He listened to my concerns and then answered them.

Oct 09, 2024
HUNTSMAN CANCER CENTER

I was extremely lucky to have found Dr. Baker. He explained my situation in a personal and professional way.

Oct 05, 2024
HUNTSMAN CANCER CENTER

Dr Baker was exceptional. He took the time to walk through my imaging and create a care plan. I felt heard and reassured.

Sep 24, 2024
HUNTSMAN CANCER CENTER

Dr Baker is a caring individual and very good Doctor in his field.

Sep 09, 2024
HUNTSMAN CANCER CENTER

Dr. Baker was absolutely excellent - first meeting, surgery day, and follow-up. He is exactly what you want your surgeon to be - concerned/caring, surgically excellent, and very interested in your recovery. Upon meeting him, I checked my concerns and fears at the door. I knew I was in good hands and his actions confirmed that. Huntsman is lucky to have Dr. Baker and I was lucky to have him as my surgeon. I am still so impressed! Oh, and his medical team was excellent, too - thank you thank you thank you.

Sep 05, 2024
HUNTSMAN CANCER CENTER

My concerns where addressed . We discussed different options to treat my tumors. I feel very confident in being in his care.

Jul 23, 2024
HUNTSMAN CANCER CENTER

Dr Baker is careful and caring about you as a patient.

Jul 03, 2024
HUNTSMAN CANCER CENTER

Dr. Baker's knowledgeable, helpful, kind.

Jul 03, 2024
HUNTSMAN CANCER CENTER

A friend recommended Dr Baker. He did my surgery well.

Jun 28, 2024
HUNTSMAN CANCER CENTER

Excellent, 100 % I will recommend Dr Baker to everyone in need of treatment regarding tumors. I feel much better now ?

Jun 20, 2024
HUNTSMAN CANCER CENTER

Very good at explaining the why the steps in treatment are needed.

Jun 12, 2024
HUNTSMAN CANCER CENTER

Dr Baker, was wonderful taking time to explain to me everything, very positive, and understanding. made me feel very comfortable.

May 25, 2024
HUNTSMAN CANCER CENTER

Explained in detail what remains to be done and the expected time frame. Glad he is taking care of me.

May 24, 2024
HUNTSMAN CANCER CENTER

Dr. Baker was great about everything he told me and listened to me about my condition and the unknown future I have

May 23, 2024
HUNTSMAN CANCER CENTER

Dr. Baker is the role model is physician excellence.

Apr 28, 2024
HUNTSMAN CANCER CENTER

Definitely glad we were referred to Dr. Marshall S. Baker - All the years of appointments and testing done and no other physician had thought about doing extensive bloodwork to look for answers. Thank you for thinking about something so simple but so important to find out what no one else could to get me on my feet. Honest about surgical options and success rates or complications afterwards. Refreshing for sure.

Apr 25, 2024
HUNTSMAN CANCER CENTER

We felt very comfortable with Dr Baker and appreciate his willingness to help us, including calling the previous surgeon and consulting with him and including another specialist that is here with Huntsman Cancer Center. Dr Baker has a kindness and willingness to help us feel good with our medical situation. Thank you for bringing him here.

Apr 12, 2024
HUNTSMAN CANCER CENTER

Dr Baker was the perfect Doctor to help me with my Health issues. I really appreciate all his help. He is very kind and understanding

Apr 11, 2024
HUNTSMAN CANCER CENTER

Dr. Baker was very kind, knowledgeable & helpful in explaining my gall bladder surgery. On the day of my surgery, he put me at ease & it was reassuring to know I was in good hands. I so appreciate his calm approach & will always be grateful for his care during a stressful time.

Mar 15, 2024
HUNTSMAN CANCER CENTER

Caring and skillful.

Mar 14, 2024
HUNTSMAN CANCER CENTER

What an incredible doctor. Professional Knowledgable, courteous.

Mar 06, 2024
HUNTSMAN CANCER CENTER

We appreciate Dr. Marshall Baker's caring attitude, as well as his ability to explain my options, and integrate the other specialists opinions with regard to my specific medical issues and concerns.

Feb 27, 2024
HUNTSMAN CANCER CENTER

Dr Baker was very nice about explaining everything that he done and what I had to have done next I give him a 10

Feb 16, 2024
HUNTSMAN CANCER CENTER

Very professional

Feb 13, 2024
HUNTSMAN CANCER CENTER

Dr. Marshall is an excellent doctor and is very compassionate and wise. I have the utmost respect for him as a doctor and a human being. I am so grateful I had him as my doctor. The entire team went above and beyond when it came to the care of their patients. Thank you.

Feb 02, 2024
HUNTSMAN CANCER CENTER

Dr Marshall is an amazing doctor. From our first visit he was very kind and knowledgeable on my condition and what we needed to do to fix it. I had every confidence in him and he was amazing throughout every step. My surgery went well and was a success. I have a lot of respect for him .

Feb 01, 2024
HUNTSMAN CANCER CENTER

Dr. Baker took the time needed and was very clear with the way he explained what the scan showed and what we need to do going forward.

Jan 20, 2024
HUNTSMAN CANCER CENTER

Dr. Baker took time to call me at home due to my anxiety over a pathology report. He reassured me and explained things clearly from day one I felt like he was very attentive and present in our meetings. He is one incredible doctor and I'm glad he's taking good care of me.

Jan 09, 2024
HUNTSMAN CANCER CENTER

Dr. Baker has explained my treatment in terms I can understand, and he has been careful in proceeding with my treatment.

Jan 04, 2024
HUNTSMAN CANCER CENTER

DR. Marshall Baker is the "A" Team for surgery. I highly recommend him for complex pancreatic surgeries.

Dec 22, 2023
HUNTSMAN CANCER CENTER

Absolutely wonderful doctor¿.compassionate, caring. Love having him as my surgeon!

Dec 17, 2023
HUNTSMAN CANCER CENTER

He is very sensitive, great listener, knowledgeable and treats you so kindly . Not rushed and not arrogant. He's great! I feel blessed to have him for my Doctor!

Nov 25, 2023
HUNTSMAN CANCER CENTER

Extremely empathetic and professional. Very through and knowledgeable. After the consultation I have a confidence and trust in a successful procedure.

Nov 21, 2023
HUNTSMAN CANCER CENTER

I have never seen a doctor that is so. Understanding understanding and sensitive to my medical needs. He seems so very Knowledgeable and gave me so much comfort annoying that he could handle my surgery. I am so grateful

Nov 08, 2023
HUNTSMAN CANCER CENTER

Top notch experience

Nov 06, 2023
HUNTSMAN CANCER CENTER

Very kind, informative and caring

Nov 03, 2023
HUNTSMAN CANCER CENTER

He explained the procedure very well. He's very open to listening to your health issues and concerns.

Nov 03, 2023
HUNTSMAN CANCER CENTER

Dr Baker was/is very kind & takes time to answer questions & listen to my concerns. He is very knowledgeable. I would highly recommend him to others.

Oct 28, 2023
HUNTSMAN CANCER CENTER

Great caring doctor.

Oct 15, 2023
HUNTSMAN CANCER CENTER

Very kind and compassionate and knowledgeable

Oct 08, 2023
HUNTSMAN CANCER CENTER

Dr Baker has been amazing. He has shown great concern and care and I really appreciate that.

Aug 24, 2023
HUNTSMAN CANCER CENTER

Professionalism; Accentuating the positive findings, as well as explaining the uncertain aspects of treatment for my condition; Thoroughness; Instilling confidence in the path of treatment.

Aug 24, 2023
HUNTSMAN CANCER CENTER

My experience with Dr. Baker was excellent. I was very satisfied with his plan for my health care.

Aug 18, 2023
HUNTSMAN CANCER CENTER

I especially enjoyed his encourgaing smiles and good nature. He clearly explained the procedures and described their goals. Dr. Baker and his staff were all excellent care givers. I always felt I was in good hands.

Aug 05, 2023
HUNTSMAN CANCER CENTER

Dr Baker is very professional. He listened to my concerns and addressed my questions. I appreciate that.

Jul 22, 2023
HUNTSMAN CANCER CENTER

He is very kind and a great listener. I trust that I'm in good hands when I have my upcoming surgery.

Jul 21, 2023
HUNTSMAN CANCER CENTER

Treated me with respect and explained my need of care/treatment in a way that I could understand. As for the procedure and aftercare everything went smoothly and better than I had anticipated. First class Doctor and person. I would highly recommend Doctor Baker anytime.

Jul 14, 2023
HUNTSMAN CANCER CENTER

He was amazing!

Jul 14, 2023
HUNTSMAN CANCER CENTER

Was very straight with me about my problems & what I need to do

Jul 13, 2023
HUNTSMAN CANCER CENTER

Dr. Baker and his staff were available, attentive, prepared, knowledgeable, not rushed. I will never be able to express my appreciation to Nancy and Perlita for listening to me when I first called and for just fighting on my behalf and to Dr. Baker for agreeing to fit me in on very short notice because I happened to be in Salt Lake getting my mother heart care. Dr. Baker and Jacee made me feel like I had no worries. No matter what they would take care of me. Dr. Baker covering all the bases with blood work and a clearer MRI to be sure what he suspected could be backed up is so appreciated. And even the assistant that made sure we were ready for the video call was so calm and confident that I knew no matter what all would be okay. There is a saying-people dont care how much you know until they know how much you care. A rare combination to find a team of people that care and have the necessary knowledge in this 2023 world. Thank you so so much. [NAME REMOVED]

Jul 03, 2023
HUNTSMAN CANCER CENTER

Dr. Seemed very care and he made it easy to understand how things work.

May 26, 2023
HUNTSMAN CANCER CENTER

We felt Dr. Baker was professional and knowledgeable, as well as caring. He was straight forward and direct while still being aware and understanding of the stress and feelings of uncertainty we were having with my diagnosis. He and the team worked together well to form a viable plan of treatment.

May 26, 2023
HUNTSMAN CANCER CENTER

I didn't totally understand why I needed chemo vs having surgery first. My primary MD explained it to me. I'm now comfortable with the plan


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Marshall Baker, MD is a surgeon-scientist with over 24 years of expertise in benign and malignant disease of the pancreas, liver, gallbladder, and bile ducts. His current clinical focus is on complex foregut oncology and hepatobiliary surgery. He recognizes that minimally invasive robotic and laparoscopic surgeries generally improve recovery and utilizes these approaches with pancreas and biliary malignancy whenever possible.

Dr. Baker’s clinical specialties Include:

  • Bile duct cancer (Cholangiocarcinoma)
  • Colorectal metastases
  • Cystic pancreatic tumors
  • Gallbladder cancer
  • Liver cancer
  • Neuroendocrine tumor of the pancreas
  • Pancreas cancer
  • Robotic liver and pancreas resection
  • Minimally invasive surgery (robotic & laparoscopic)

Dr. Baker has had a life-long passion for education and is currently a professor of surgery in the Department of Surgery at University of Utah Health, Spencer Fox Eccles School of Medicine, and serves as the Director of Surgical Simulation and the Associate Clerkship Director. His research lab continues to refine concepts of best practice in oncology using informatics-based comparative effectiveness study.

Dr. Baker earned his undergraduate degree from Duke University and medical degree from Dartmouth Medical School. He completed general surgery residency at Northwestern University. While at Northwestern, he pursued a three-year post-doctoral research fellowship in transplant immunology and obtained a master’s degree in business administration with a focus on health industry management and finance from the Kellogg School of Business. Following residency, he completed a clinical fellowship in advanced hepatopancreaticobiliary surgery at Indiana University Medical School.

Dr. Baker started his clinical practice and academic career in Chicago. He served sequentially on the faculties of Northwestern University Feinberg School of Medicine, the University of Chicago Pritzker School of Medicine, and Loyola University of Chicago Stritch School of Medicine where he was promoted to full professor. During these years, he developed and was recognized for clinical expertise in minimally invasive laparoscopic and robotic approaches to foregut oncology. He had a productive clinical research lab which employed advanced analytics to evaluate clinical outcomes and cost effectiveness for different treatment approaches to foregut malignancy.

Board Certification and Academic Information

Academic Departments Surgery -Professor (Clinical)
Academic Divisions Surgical Oncology

Education history

Undergraduate Chemistry with Distinction - Duke University B.S.
Professional Medical Medicine - Dartmouth Medical School M.D.
Internship/Residency Surgery - Categorical - Georgetown University Hospital Intern/Resident
Postdoctoral Fellowship Organ Transplantation - Northwestern University Feinberg School of Medicine Postdoctoral Research Fellow
Graduate Training Business Administration - Northwestern University Kellogg School of Management M.B.A.
Residency Surgery - Categorical - Northwestern University Feinberg School of Medicine Resident
Chief Resident Surgery - Northwestern University Feinberg School of Medicine Chief Resident
Fellowship Hepatobiliary and Pancreatic Surgery - Indiana University Medical Center Fellow

Selected Publications

Journal Article

  1. Park SS, Verm RA, Park DD, Abdelsattar ZM, Luchette FA, Baker TB, Baker M (2026). Does spending for subspecialty care in advanced-stage melanoma matter: Are greater access costs actually associated with increased use of immune therapy and improved survival among patients with low income?. Surgery, 191, 109906.
  2. Wolansky RL, Kendall MA, Zander T, Sujka J, Kuo PC, Baker M (2026). Resected intrahepatic cholangiocarcinoma: Is adjuvant chemotherapy associated with improved overall survival?. American journal of surgery, 252, 116761.
  3. VanSant-Webb CH, Geranios KC, Weldon Gilcrease G, Baker TB, Cizman Z, Smith T, Ray C, Baker M (2026). Intrahepatic cholangiocarcinoma: Does liver directed therapy provide effective local disease control?. American journal of surgery, 251, 116697.
  4. Odeh AM, Verm RA, Baker MS, Raad W, Freeman R, Abdelsattar Z (2025). Thoracic Surgeons' Practice Patterns and Attitudes Toward Preoperative Testing for Blood Resource Use: An International Survey. Annals of thoracic surgery short reports, 3(4), 844-849.
  5. Odeh AM, Verm R, Kwak J, Baker MS, Lozanoski M, Helenowski I, Vigneswaran W, Lubawski J, Raad W, Freeman RK, Abdelsattar Z (2025). Implementation and Validation of Decision-Aid Tool to Reduce Unnecessary Testing Before Thoracic Surgery. Journal of the American College of Surgeons, 241(2), 241-251.
  6. Park SS, Verm RA, Abdelsattar ZM, Luchette FA, Baker TB, Baker M (2025). Are Access Costs and Income Associated With Treatment Decision-Making and Clinical Outcomes in Rural Patients Presenting With Upper Gastrointestinal Malignancy?. Journal of surgical oncology, 132(1), 70-79.
  7. Geranios KC, Littau MS, Park SS, Baker TB, Gilcrease GW, Cizman Z, Smith T, Baker M (2024). Localized hepatocellular carcinoma: Is liver-directed therapy alone as efficacious as surgical resection?. Surgery, 179, 108939.
  8. Kramer SP, Swanson J, Fernando M, Park S, Verm R, Abdelsattar Z, Cohn T, Luchette FA, Baker M (2024). Locally Advanced Adenocarcinoma of the Esophagus: Is Esophagectomy Associated with Improved Overall Survival?. Journal of the American College of Surgeons, 239(1), 68-75.
  9. Strelko O, Swanson J, Woldt P, Frazzetta J, Simon J, Ng I, Baker MS, Barton KP, Thakkar JP, Prabhu VC, Germanwala A (2024). National Trends and Factors Associated with Voluntary Refusal of Glioblastoma Treatment: A Retrospective Review of the National Cancer Database. World neurosurgery, 189, e419-e426.
  10. Kramer SP, Tonelli C, Luchette FA, Swanson J, Abdelsattar Z, Cohn T, Baker M (2024). Locally advanced pancreatic cancer: Is surgical palliation associated with improved clinical outcome relative to medical palliation?. American journal of surgery, 230, 73-77.
  11. Park SS, Verm RA, Abdelsattar ZM, Kramer S, Swanson J, Fernando M, Cohn T, Luchette FA, Baker M (2024). Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?. American journal of surgery, 230, 63-67.
  12. Park SS, Verm RA, Abdelsattar ZM, Kramer S, Swanson J, Fernando M, Cohn T, Luchette FA, Baker M (2024). Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?. Surgery, 175(3), 695-703.
  13. Swanson J, Baker MS, Fernando M, Luchette FA, Cohn (2024). Association between COVID-19 diagnosis and postoperative outcomes in sleeve gastrectomy and Roux-en-Y gastric bypass: A national cohort study. American journal of surgery, 230, 43-46.
  14. Swanson J, Roat-Shumway S, Cohn T, Luchette FA, Abdelsattar Z, Baker M (2024). Esophageal cancer: Does inaccuracy in clinical staging affect our ability to reach optimal outcomes?. Surgery, 175(2), 342-346.
  15. Odeh A, Verm R, Park S, Swanson J, Baker M, Abdelsattar (2024). Fragmented care, Commission on Cancer Accreditation and Overall Survival in Patients Receiving Surgery and Chemotherapy for Lung Cancer. The Annals of thoracic surgery,
  16. Verm RA, Baker MS, Cohn T, Park S, Swanson J, Freeman R, Abdelsattar ZM (2024). Fragmented Care, Commission on Cancer Accreditation and Overall Survival in Patients Receiving Surgery and Chemotherapy for Esophageal Cancer. National Library of Medicine Classification, 175(3), 318-628.
  17. Tonelli CM, Cohn T, Abdelsattar Z, Luchette FA, Baker MS (2023). Association of Resident Independence With Short-term Clinical Outcome in Core General Surgery Procedures.(Epub ahead of print). JAMA Surg.
  18. Swanson J, Littau M, Tonelli C, Cohn T, Luchette FA, Abdelsattar Z, Baker MS (2023). The role of endoscopic resection in early-stage esophageal adenocarcinoma: Esophagectomy is associated with improved survival in patients presenting with clinical stage T1bN0 disease. Surgery, 173(3), 693-701.
  19. Roat-Shumway S, Tonelli C, Singer M, Cohn T, Luchette FA, Abdelsattar Z, Baker MS (2023). Is local excision an appropriate treatment modality in patients presenting with early-stage (cT1 N0 M0) rectal adenocarcinoma? Surgery, 173(3), 665-673.
  20. Kramer SP, Tonelli C, Abdelsattar Z, Cohn T, Luchette FA, Baker M (2023). Rectal neuroendocrine tumors: Can they be observed?. Surgery, 174(5), 1161-1167.
  21. Tonelli CM, Kulshrestha S, Singer M, Pawlik TM, Luchette FA, Abdelsattar ZM, Baker MS (2023). Use of a national registry to define a composite quality metric for rectal cancer. American journal of surgery, 225(3), 514-518.
  22. Swanson J, Littau M, Tonneli C, Luchette FA, Abdelsattar Z, Baker M (2023). A matched cohort comparison of endoscopic resection, chemoradiation and esophagectomy in the treatment of early-stage eesophageal squamous cell carcinoma. American journal of surgery, 225(3), 508-513.
  23. Tonelli CM, Baker MS, Luchette FA, Cohn (2023). Laparoscopic and robotic parasesophageahernia repair in United States veterans: Clinical outcomes and risk factors associated with reoperation for recurrence. American journal of surgery, 225(3), 508-513.
  24. Kim P, Littau M, Baker TB, Abdelsattar Z, Tonelli C, Bunn C, Kulshrestha S, Luchette FA, Baker MS (2022). Intrahepatic cholangiocarcinoma: Is there a role for liver transplantation? Surgery, 171(3), 741-746.
  25. Kulshrestha S, Sweigert PJ, Tonelli C, Bunn C, Luchette FA, Abdelsattar ZM, Pawlik TM, Baker MS (2022). Textbook oncologic outcome in pancreaticoduodenectomy: Do regionalization efforts make sense? J Surg Oncol, 125(3), 414-424.
  26. Littau MJ, Kim P, Kulshrestha S, Bunn C, Tonelli C, Abdelsattar ZM, Luchette FA, Baker MS (2022). Resectable intrahepatic and hilar cholangiocarcinoma: Is margin status associated with survival? Surgery, 171(3), 703-710.
  27. Tonelli CM, Lorenzo I, Bunn C, Kulshrestha S, Agnew SP, Abdelsattar ZM, Luchette FA, Baker MS (2022). Does resident autonomy in colectomy procedures result in inferior clinical outcomes? Surgery, 171(3), 598-606.
  28. Littau MJ, Bunn C, Kim P, Kulshrestha S, Tonelli C, Abdelsattar ZM, Luchette FA, Baker MS (2022). Low and moderate grade retroperitoneal liposarcoma: Is adjuvant radiotherapy associated with improved survival in patients undergoing R1 resection? Am J Surg, 223(3), 527-530.
  29. Patel DJ, Bunn C, Kulshrestha S, Tonelli C, Littau M, Kim P, Luchette F, Abdelsattar Z, Baker MS (2022). Small-sized gastrointestinal stromal tumors: Is there an association between expectant management and overall survival? Am J Surg, 223(3), 521-525.
  30. Lorenzo IL, Tonelli CM, Bunn C, Kulshrestha S, Agnew SP, Cohn TD, Abdelsattar ZM, Baker MS, Luchette FA (2022). Supervised independence in elective inguinal hernia repairs performed by surgical residents is not associated with compromised short clinical outcome or rates of reoperation for recurrence. Am J Surg, 223(3), 470-474.
  31. Kulshrestha S, Vigneswaran WT, Pawlik TM, Baker MS, Luchette FA, Raad W, Abdelsattar ZM, Freeman RK, Grenda T, Lubawski J, Loyola Thoracic Outcomes Group (2022). Assessment of Textbook Outcome After Surgery for Stage I/II Non-small Cell Lung Cancer. Semin Thorac Cardiovasc Surg, 34(4), 1351-1359.
  32. Littau MJ, Freeman R, Vigneswaran WT, Luchette FA, Baker MS, Raad W, Abdelsattar ZM, Loyola Thoracic Outcomes Group (2022). Comparative effectiveness of stereotactic body radiation therapy versus surgery for stage I lung cancer in otherwise healthy patients: An instrumental variable analysis. JTCVS Open, 9, 249-261.
  33. Tonelli CM, Lorenzo I, Bunn C, Kulshrestha S, Abdelsattar ZM, Cohn T, Luchette FA, Baker MS (2022). Contemporary Matched-Cohort Comparison of Surgical Approach to Inguinal Hernia Repair: Are Minimally Invasive Approaches Associated with Higher Rates of Recurrence? J Am Coll Surg, 235(1), 119-127.
  34. Tonelli CM, Lorenzo I, Bunn C, Kulshrestha S, Cohn T, Abdelsattar Z, Luchette FA, Baker MS (2022). Are Residents Able to Perform a Laparoscopic Cholecystectomy with Acceptable Outcomes When the Attending Is Not Scrubbed? J Am Coll Surg, 235(1), 60-68.
  35. Kulshrestha S, Penton A, Luchette FA, Baker MS, Abdelsattar ZM (2022). Variation in Hospital Cost and 1-Year Episodes of Care after Diaphragmatic Hernia Repair. J Am Coll Surg, 235(1), 111-118.
  36. Kim P, Littau M, Baker TB, Abdelsattar Z, Tonelli C, Bunn C, Kulshrestha S, Luchette FA, Scaglione S, Baker MS (2022). The benefit of liver transplant beyond Milan criteria: An analysis using the National Cancer Database. Surgery, 172(6), 1823-1828.
  37. Sweigert PJ, Eguia E, Baker MS, Link CM, Hyer JM, Paredes AZ, Tsilimigras DI, Husain S, Pawlik TM (2021). Assessment of Cancer Center Variation in Textbook Oncologic Outcomes Following Colectomy for Adenocarcinoma. J Gastrointest Surg, 25(3), 775-785.
  38. Eguia E, Fahmy JN, Cobb AN, Sweigert P, Aranha GV, Abood G, Kuo PC, Baker MS (2021). Non-Hispanic Blacks undergoing distal pancreatectomy have higher risk-adjusted rates of morbidity and are more likely to be high-cost outliers. Am J Surg, 221(4), 759-763.
  39. Al Asadi A, Hubbs DM, Sweigert PJ, Baker MS, Kabaker AS (2021). Analysis of adjuvant chemotherapy in patients undergoing curative-intent resection of localized adrenocortical carcinoma. Am J Surg, 222(1), 119-125.
  40. Sweigert PJ, Wang X, Eguia E, Baker MS, Kulshrestha S, Tsilimigras DI, Ejaz A, Pawlik TM (2021). Does minimally invasive pancreaticoduodenectomy increase the chance of a textbook oncologic outcome? Surgery, 170(3), 880-888.
  41. Sweigert PJ, Eguia E, Nelson MH, Bunn C, Kulshrestha S, Luchette FA, Baker MS (2021). Biliary Enteric Reconstruction After Biliary Injury: Delayed Repair Is More Costly Than Early Repair. J Surg Res, 257, 349-355.
  42. Eguia E, Aranha GV, Abood G, Godellas C, Kuo PC, Baker MS (2021). Do high-volume centers mitigate complication risk and reduce costs associated with performing pancreaticoduodenectomy in ethnic minorities? Am J Surg, 222(1), 153-158.
  43. Eguia E, Sweigert PJ, Li RD, Kuo PC, Janjua H, Abood G, Baker MS (2021). Laparoscopic partial hepatectomy is cost-effective when performed in high volume centers: A five state analysis. Am J Surg, 222(3), 577-583.
  44. Kulshrestha S, Bunn C, Gonzalez R, Afshar M, Luchette FA, Baker MS (2021). Unhealthy alcohol and drug use is associated with an increased length of stay and hospital cost in patients undergoing major upper gastrointestinal and pancreatic oncologic resections. Surgery, 169(3), 636-643.
  45. Bunn C, Kulshrestha S, Di Chiaro B, Maduekwe U, Abdelsattar ZM, Baker MS, Luchette FA, Agnew S (2021). A Leg to Stand on: Trauma Center Designation and Association with Rate of Limb Salvage in Patients Suffering Severe Lower Extremity Injury. J Am Coll Surg, 233(1), 120-129.e5.
  46. Patel DJ, Kulshrestha S, Bunn C, Littau M, Agnew S, Baker MS (2021). Positive microscopic surgical margins: Is there an association with survival in resected small gastrointestinal stromal tumors? Am J Surg, 221(3), 549-553.
  47. Littau MJ, Kulshrestha S, Bunn C, Agnew S, Sweigert P, Luchette FA, Baker MS (2021). The importance of the margin of resection and external radiation in non-lipomatous retroperitoneal sarcoma. Am J Surg, 221(3), 543-548.
  48. Littau MJ, Kulshrestha S, Bunn C, Agnew S, Sweigert P, Luchette FA, Baker MS (2021). The importance of the margin of resection and radiotherapy in retroperitoneal liposarcoma. Am J Surg, 221(3), 554-560.
  49. Littau MJ, Kulshrestha S, Bunn C, Kim P, Luchette FA, Baker MS (2021). Is positive histologic surgical margin associated with overall survival in patients with resectable gallbladder cancer? Surg Open Sci, 6, 15-20.
  50. Kulshrestha S, Janjua HM, Bunn C, Rogers M, DuCoin C, Abdelsattar ZM, Luchette FA, Kuo PC, Baker MS (2021). State-Level Examination of Clinical Outcomes and Costs for Robotic and Laparoscopic Approach to Diaphragmatic Hernia Repair. J Am Coll Surg, 233(1), 9-19.e2.
  51. Kulshrestha S, Dligach D, Joyce C, Baker MS, Gonzalez R, O'Rourke AP, Glazer JM, Stey A, Kruser JM, Churpek MM, Afshar M (2021). Prediction of severe chest injury using natural language processing from the electronic health record. Injury, 52(2), 205-212.
  52. Cousin-Peterson E, Janjua HM, Barry TM, Baker MS, Kuo PC (2021). Discharge timing: Does targeting an ideal length of stay for patients undergoing colectomy impact readmissions and costs of care? Am J Surg, 221(3), 570-574.
  53. Rogers MP, Cousin-Peterson E, Barry TM, Baker MS, Kuo PC, Janjua HM (2021). Elements of the care environment influence coronary artery bypass surgery readmission. Surg Open Sci, 7, 12-17.
  54. Bunn C, Kulshrestha S, Boyda J, Balasubramanian N, Birch S, Karabayir I, Baker M, Luchette F, Modave F, Akbilgic O (2021). Application of machine learning to the prediction of postoperative sepsis after appendectomy. Surgery, 169(3), 671-677.
  55. Bunn C, Ringhouse B, Patel P, Baker M, Gonzalez R, Abdelsattar ZM, Luchette FA (2021). Trends in utilization of whole-body computed tomography in blunt trauma after MVC: Analysis of the Trauma Quality Improvement Program database. J Trauma Acute Care Surg, 90(6), 951-958.
  56. Bunn C, Kulshrestha S, Boyda J, Balasubramania N, Birch S, Karabayir I, Baker MS, Modave F, Akbilgic (2021). The Application of Machine Learning to the Prediction of Postoperative Sepsis Following Appendectomy. American journal of surgery, 222(1), 153-158.
  57. Eguia E, Baker MS, Chand B, Sweigert PJ, Kuo PC (2020). The impact of the affordable care act (ACA) Medicaid Expansion on access to minimally invasive surgical care. Am J Surg, 219(1), 15-20.
  58. Eguia E, Baker MS, Bechara C, Shames M, Kuo PC (2020). The Impact of the Affordable Care Act Medicaid Expansion on Vascular Surgery. Ann Vasc Surg, 66, 454-461.e1.
  59. Patel DJ, Lutfi W, Sweigert P, Eguia E, Abood G, Knab L, Kuo PC, Baker MS (2020). Clinically resectable acinar cell carcinoma of the pancreas: Is there a benefit to adjuvant systemic therapy? Am J Surg, 219(3), 522-526.
  60. Patel DJ, Lutfi W, Sweigert P, Eguia E, Abood G, Knab L, Kuo PC, Baker MS (2020). Adjuvant systemic therapy for intermediate and large gastric gastrointestinal stromal tumors (GISTs): Is there a survival benefit following margin negative surgical resection? Am J Surg, 219(3), 436-439.
  61. Sweigert PJ, Chen C, Fahmy JN, Eguia E, Ban KA, deLahunta D, Peters S, Baker MS, Singer MA (2020). Association of obesity with postoperative outcomes after proctectomy. Am J Surg, 220(4), 1004-1009.
  62. Janjua H, Cousin-Peterson E, Barry TM, Kuo MC, Baker MS, Kuo PC (2020). The paradox of the robotic approach to inguinal hernia repair in the inpatient setting. Am J Surg, 219(3), 497-501.
  63. Sweigert PJ, Eguia E, Baker MS, Paredes AZ, Tsilimigras DI, Dillhoff M, Ejaz A, Cloyd J, Tsung A, Pawlik TM (2020). Assessment of textbook oncologic outcomes following pancreaticoduodenectomy for pancreatic adenocarcinoma. J Surg Oncol, 121(6), 936-944.
  64. Sweigert PJ, Eguia E, Janjua H, Nassoiy SP, Knab LM, Abood G, Kuo PC, Baker MS (2020). Does resection improve overall survival for intrahepatic cholangiocarcinoma with nodal metastases? Surg Open Sci, 2(3), 107-112.
  65. Eguia E, Bunn C, Kulshrestha S, Markossian T, Durazo-Arvizu R, Baker MS, Gonzalez R, Behzadi F, Churpek M, Joyce C, Afshar M (2020). Trends, Cost, and Mortality From Sepsis After Trauma in the United States: An Evaluation of the National Inpatient Sample of Hospitalizations, 2012-2016. Crit Care Med, 48(9), 1296-1303.
  66. Janjua H, Cousin-Peterson E, Barry TM, Kuo MC, Baker MS, Kuo PC (2020). Robotic Approach to Outpatient Inguinal Hernia Repair. J Am Coll Surg, 231(1), 61-72.
  67. Bajic P, Patel PM, Nelson MH, Dornbier RA, Kirshenbaum EJ, Baker MS, Farooq AV, McVary KT, Gupta GN, Bresler L (2020). Penile Prosthesis Implantation and Timing Disparities After Radical Prostatectomy: Results From a Statewide Claims Database. J Sex Med, 17(6), 1175-1181.
  68. Kulshrestha S, Bunn C, Patel PM, Sweigert PJ, Eguia E, Pawlik TM, Baker MS (2020). Textbook oncologic outcome is associated with increased overall survival after esophagectomy. Surgery, 168(5), 953-961.
  69. Patel DJ, Lutfi W, Eguia E, Sweigert P, Knab L, Abood G, Baker MS (2020). Adjuvant systemic therapy for small bowel gastrointestinal stromal tumor (GIST): Is there a survival benefit after R0 resection? Surgery, 168(4), 695-700.
  70. Knab LM, Varsanik M, Li R, Chen C, Pak N, Eguia E, Renz C, Terrasse W, Gauthier M, Ko C, Baker M, Parada JP, Abood G (2020). Antimicrobial susceptibility of biliary stents do not predict infectious complications after whipple. Surgery, 168(3), 457-461.
  71. Nelson M, Dornbier R, Kirshenbaum E, Eguia E, Sweigert P, Baker M, Farooq A, McVary KT, Gonzalez CM, Gupta G, Bresler L (2020). Use of Surgery for Post-Prostatectomy Incontinence. J Urol, 203(4), 786-791.
  72. Patel PM, Doshi CP, Belshoff A, Nelson M, Sweigert PJ, Bunn C, Kulshrestha S, Baker MS, Woods M, Gupta GN (2020). Optimal Cystectomy Outcome: A Composite Measurement Evaluating Quality of Care and Mortality Benefit. National Library of Medicine Classification, 143, 117-122.
  73. Liu JB, Baker MS, Thompson VM, Kilbane EM, Pitt HA (2019). Wound protectors mitigate superficial surgical site infections after pancreatoduodenectomy. HPB (Oxford), 21(1), 121-131.
  74. Eguia E, Kuo PC, Sweigert P, Nelson M, Aranha GV, Abood G, Godellas CV, Baker MS (2019). The laparoscopic approach to distal pancreatectomy is a value-added proposition for patients undergoing care in moderate-volume and high-volume centers. Surgery, 166(2), 166-171.
  75. Sweigert PJ, Eguia E, Nelson MH, Nassoiy SP, Knab LM, Abood G, Baker MS (2019). Total gastrectomy in patients with gastric adenocarcinoma: Is there an advantage to the minimally invasive approach? Surgery, 166(4), 623-631.
  76. Sweigert PJ, Eguia E, Kothari AN, Ban KA, Nelson MH, Baker MS, Singer MA (2019). Do prolonged operative times obviate the benefits associated with minimally invasive colectomy? Surgery, 166(3), 336-341.
  77. Eguia E, Cobb AN, Baker MS, Joyce C, Gilbert E, Gonzalez R, Afshar M, Churpek MM (2019). Risk factors for infection and evaluation of Sepsis-3 in patients with trauma. Am J Surg, 218(5), 851-857.
  78. Eguia E, Kuo PC, Sweigert PJ, Nelson MH, Aranha GV, Abood G, Godellas C, Baker MS (2019). The laparoscopic approach to pancreatoduodenectomy is cost neutral in very high-volume centers. Surgery, 166(6), 1027-1032.
  79. Petrova E, Lapshyn H, Bausch D, D'Haese J, Werner J, Klier T, Nüssler NC, Gaedcke J, Ghadimi M, Uhl W, Belyaev O, Kantor O, Baker M, Keck T, Wellner UF, StuDoQ,Pancreas study group and members of StuDoQ,Pancreas registry of the German Society for General and Visceral Surgery (DGAV) (2019). Risk stratification for postoperative pancreatic fistula using the pancreatic surgery registry StuDoQ|Pancreas of the German Society for General and Visceral Surgery. Pancreatology, 19(1), 17-25.
  80. Benjamin AJ, Baker TB, Talamonti MS, Bodzin AS, Schneider AB, Winschester DJ, Roggin KK, Bentrem DJ, Suss NR, Baker MS (2018). Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function. Surgery, 163(3), 582-586.
  81. Kantor O, Pitt HA, Talamonti MS, Roggin KK, Bentrem DJ, Prinz RA, Baker MS (2018). Minimally invasive pancreatoduodenectomy: is the incidence of clinically relevant postoperative pancreatic fistula comparable to that after open pancreatoduodenectomy? Surgery, 163(3), 587-593.
  82. Suss NR, Talamonti MS, Bryan DS, Wang CH, Kuchta KM, Stocker SJ, Bentrem DJ, Roggin KK, Winchester DJ, Marsh R, Prinz RA, Murad FM, Baker MS (2018). Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer? Surgery, 163(5), 1047-1052.
  83. de W Marsh R, Talamonti MS, Baker MS, Posner M, Roggin K, Matthews J, Catenacci D, Kozloff M, Polite B, Britto M, Wang C, Kindler H (2018). Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. J Surg Oncol, 117(3), 354-362.
  84. Kantor O, Talamonti MS, Wang CH, Roggin KK, Bentrem DJ, Winchester DJ, Prinz RA, Baker MS (2018). The extent of vascular resection is associated with perioperative outcome in patients undergoing pancreaticoduodenectomy. HPB (Oxford), 20(2), 140-146.
  85. Lutfi W, Talamonti MS, Kantor O, Wang CH, Stocker SJ, Bentrem DJ, Roggin KK, Winchester DJ, Marsh R, Prinz RA, Baker MS (2017). Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer. Am J Surg, 213(3), 521-525.
  86. Liu JB, Baker TB, Suss NR, Talamonti MS, Roggin KK, Winchester DJ, Baker MS (2017). Orthotopic liver transplantation provides a survival advantage compared with resection in patients with hepatocellular carcinoma and preserved liver function. Surgery, 162(5), 1032-1039.
  87. Kantor O, Talamonti MS, Pitt HA, Vollmer CM, Riall TS, Hall BL, Wang CH, Baker MS (2017). Using the NSQIP Pancreatic Demonstration Project to Derive a Modified Fistula Risk Score for Preoperative Risk Stratification in Patients Undergoing Pancreaticoduodenectomy. J Am Coll Surg, 224(5), 816-825.
  88. Kantor O, Talamonti MS, Sharpe S, Lutfi W, Winchester DJ, Roggin KK, Bentrem DJ, Prinz RA, Baker MS (2017). Laparoscopic pancreaticoduodenectomy for adenocarcinoma provides short-term oncologic outcomes and long-term overall survival rates similar to those for open pancreaticoduodenectomy. Am J Surg, 213(3), 512-515.
  89. Kantor O, Bryan DS, Talamonti MS, Lutfi W, Sharpe S, Winchester DJ, Prinz RA, Baker MS (2017). Laparoscopic Distal Pancreatectomy for Cancer Provides Oncologic Outcomes and Overall Survival Identical to Open Distal Pancreatectomy. J Gastrointest Surg, 21(10), 1620-1625.
  90. Kantor O, Talamonti MS, Stocker SJ, Wang CH, Winchester DJ, Bentrem DJ, Prinz RA, Baker MS (2016). A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer. J Gastrointest Surg, 20(2), 284-92.
  91. In H, Kantor O, Sharpe SM, Baker MS, Talamonti MS, Posner MC (2016). Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy. Ann Surg Oncol, 23(6), 1956-62.
  92. Lutfi W, Talamonti MS, Kantor O, Wang CH, Liederbach E, Stocker SJ, Bentrem DJ, Roggin KK, Winchester DJ, Marsh R, Prinz RA, Baker MS (2016). Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head. Surgery, 160(3), 714-24.
  93. Kantor O, Talamonti MS, Lutfi W, Wang CH, Winchester DJ, Marsh R, Prinz RA, Baker MS (2016). External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma. Surgery, 160(6), 1466-1476.
  94. Sharpe SM, In H, Winchester DJ, Talamonti MS, Baker MS (2015). Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors. J Gastrointest Surg, 19(1), 117-23; discussion 123.
  95. Sur MD, In H, Sharpe SM, Baker MS, Weichselbaum RR, Talamonti MS, Posner MC (2015). Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol, 22(7), 2209-17.
  96. Sharpe SM, Talamonti MS, Wang E, Bentrem DJ, Roggin KK, Prinz RA, Marsh RD, Stocker SJ, Winchester DJ, Baker MS (2015). The laparoscopic approach to distal pancreatectomy for ductal adenocarcinoma results in shorter lengths of stay without compromising oncologic outcomes. Am J Surg, 209(3), 557-63.
  97. Zyromski NJ, Baker MS (2015). Proceedings of the 49th Annual Pancreas Club Meeting. J Gastrointest Surg, 19(12), 2258-63.
  98. Sharpe SM, Talamonti MS, Wang CE, Prinz RA, Roggin KK, Bentrem DJ, Winchester DJ, Marsh RD, Stocker SJ, Baker MS (2015). Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base. J Am Coll Surg, 221(1), 175-84.
  99. Baker MS, Sherman KL, Stocker SJ, Hayman AV, Bentrem DJ, Prinz RA, Talamonti MS (2014). Using a modification of the Clavien-Dindo system accounting for readmissions and multiple interventions: defining quality for pancreaticoduodenectomy. J Surg Oncol, 110(4), 400-6.
  100. Hayman AV, Stocker SJ, Baker MS, Bentrem DJ, Prinz RA, Marsh Rde W, Talamonti MS (2014). CA 19-9 nonproduction is associated with poor survival after resection of pancreatic adenocarcinoma. Am J Clin Oncol, 37(6), 550-4.
  101. Cherenfant J, Talamonti MS, Hall CR, Thurow TA, Gage MK, Stocker SJ, Lapin B, Wang E, Silverstein JC, Mangold K, Odeleye M, Kaul KL, Lamzabi I, Gattuso P, Winchester DJ, Marsh RW, Roggin KK, Bentrem DJ, Baker MS, Prinz RA (2014). Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors. Surgery, 156(6), 1504-10; discussion 1510-1.
  102. Baker MS, Sherman KL, Stocker S, Hayman AV, Bentrem DJ, Prinz RA, Talamonti MS (2013). Defining quality for distal pancreatectomy: does the laparoscopic approach protect patients from poor quality outcomes? J Gastrointest Surg, 17(2), 273-80.
  103. Cherenfant J, Stocker SJ, Gage MK, Du H, Thurow TA, Odeleye M, Schimpke SW, Kaul KL, Hall CR, Lamzabi I, Gattuso P, Winchester DJ, Marsh RW, Roggin KK, Bentrem DJ, Baker MS, Prinz RA, Talamonti MS (2013). Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. Surgery, 154(4), 785-91; discussion 791-3.
  104. Sweigert PJ, Eguia E, Nelson MH, Bunn C, Kulshrestha S, Luchette FA, Baker M (2012). Early Biliary Enteric Reconstruction After Bile Duct Injury Is Less Costly Than Delayed Repair. The Journal of surgical research, 257, 349-355.
  105. Baker MS, Bentrem DJ, Ujiki MB, Stocker S, Talamonti MS (2011). Adding days spent in readmission to the initial postoperative length of stay limits the perceived benefit of laparoscopic distal pancreatectomy when compared with open distal pancreatectomy. Am J Surg, 201(3), 295-9; discussion 299-300.
  106. Fronza JS, Bentrem DJ, Baker MS, Talamonti MS, Ujiki MB (2010). Laparoscopic distal pancreatectomy using radiofrequency energy. Am J Surg, 199(3), 401-4; discussion 404.
  107. Baker MS, Bentrem DJ, Ujiki MB, Stocker S, Talamonti MS (2009). A prospective single institution comparison of peri-operative outcomes for laparoscopic and open distal pancreatectomy. Surgery, 146(4), 635-43; discussion 643-5.
  108. Pitt SC, Pitt HA, Baker MS, Christians K, Touzios JG, Kiely JM, Weber SM, Wilson SD, Howard TJ, Talamonti MS, Rikkers LF (2009). Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? J Gastrointest Surg, 13(9), 1692-8.
  109. Baker MS, Knuth JL, DeWitt J, LeBlanc J, Cramer H, Howard TJ, Schmidt CM, Lillemoe KD, Pitt HA (2008). Pancreatic cystic neuroendocrine tumors: preoperative diagnosis with endoscopic ultrasound and fine-needle immunocytology. J Gastrointest Surg, 12(3), 450-6.
  110. Howard TJ, Browne JS, Zyromski NJ, Lavu H, Baker MS, Shen C, Madura JA (2008). Mechanisms of primary operative failure and results of remedial operation in patients with chronic pancreatitis. J Gastrointest Surg, 12(12), 2087-95; discussion 2095-6.
  111. Lavu H, Knuth JL, Baker MS, Shen C, Zyromski NJ, Schmidt M, Nakeeb A, Howard TJ (2008). Middle segment pancreatectomy can be safely incorporated into a pancreatic surgeon's clinical practice. HPB (Oxford), 10(6), 491-7.
  112. Schmidt CM, White PB, Waters JA, Yiannoutsos CT, Cummings OW, Baker M, Howard TJ, Zyromski NJ, Nakeeb A, DeWitt JM, Akisik FM, Sherman S, Pitt HA, Lillemoe KD (2007). Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg, 246(4), 644-51; discussion 651-4.
  113. Chen X, Zhang X, Larson CS, Baker MS, Kaufman DB (2006). In vivo bioluminescence imaging of transplanted islets and early detection of graft rejection. Transplantation, 81(10), 1421-7.
  114. Blomeier H, Zhang X, Rives C, Brissova M, Hughes E, Baker M, Powers AC, Kaufman DB, Shea LD, Lowe WL Jr (2006). Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation. Transplantation, 82(4), 452-9.
  115. Leventhal JR, Sun J, Zhang J, Galili U, Chong A, Baker M, Kaufman DB, Wright JR Jr (2004). Evidence that tilapia islets do not express alpha-(1,3)gal: implications for islet xenotransplantation. Xenotransplantation, 11(3), 276-83.
  116. Baker MS, Chen X, Rotramel A, Nelson J, Kaufman DB (2003). Proinflammatory cytokines induce NF-kappaB-dependent/NO-independent chemokine gene expression in MIN6 beta cells. J Surg Res, 110(1), 295-303.
  117. Baker MS, Chen X, Rotramel AR, Nelson JJ, Kaufman DB (2003). Interferon regulatory factor-1 down-regulates cytokine-induced IP-10 expression in pancreatic islets. Surgery, 134(2), 134-41.
  118. Baker MS, Chen X, Rotramel AR, Nelson JJ, Lu B, Gerard C, Kanwar Y, Kaufman DB (2003). Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients. Surgery, 134(2), 126-33.
  119. Kaufman DB, Baker MS, Chen X, Leventhal JR, Stuart FP (2002). Sequential kidney/islet transplantation using prednisone-free immunosuppression. Am J Transplant, 2(7), 674-7.
  120. Baker MS, Chen X, Cao XC, Kaufman DB (2001). Expression of a dominant negative inhibitor of NF-kappaB protects MIN6 beta-cells from cytokine-induced apoptosis. J Surg Res, 97(2), 117-22.
  121. Wu JJ, Chen X, Cao XC, Baker MS, Kaufman DB (2001). Cytokine-induced metabolic dysfunction of MIN6 beta cells is nitric oxide independent. J Surg Res, 101(2), 190-5.
  122. Sane DC, Baker MS (1993). Human platelets possess tyrosylprotein sulfotransferase (TPST) activity. Thromb Haemost, 69(3), 272-5.

Review

  1. Eguia E, Baker T, Baker (2024). Hepatocellular Carcinoma: Surgical Management and Evolving Therapies. Cancer treatment and research, 192, 185-206.
  2. Liu JB, Baker MS (2016). Surgical Management of Pancreatic Neuroendocrine Tumors. [Review]. Surg Clin North Am, 96, (6), 1447-1468.
  3. Kantor O, Baker MS (2016). Hepatocellular Carcinoma: Surgical Management and Evolving Therapies. [Review]. Cancer Treat Res, 168, 165-83.
  4. Zyromski NJ, Baker M (2016). Summary of the 50th annual Pancreas Club meeting proceedings. Journal of gastrointestinal surgery, 21(4), 749-754.
  5. Zyromski NJ, Baker M (2015). Summary of the 49th annual Pancreas Club meeting proceedings. Journal of gastrointestinal surgery, 19, 2258-2263.
  6. Zyromski NJ, Baker M (2014). Summary of the 48th annual Pancreas Club meeting proceedings. Journal of gastrointestinal surgery, 18, 1385-1390.
  7. Zyromski NJ, Baker M (2013). Summary of the 46th annual Pancreas Club meeting proceedings. Journal of gastrointestinal surgery, 17, 576-80.
  8. Zyromski NJ, Baker M (2013). Summary of the 47th annual Pancreas Club meeting proceedings. Journal of gastrointestinal surgery, 17, 1819-1823.
  9. Zyromski NJ, Baker MS (2012). Summary of the 45th annual Pancreas Club meeting proceedings. [Review]. J Gastrointest Surg, 16, (5), 935-45.
  10. Marsh Rde W, Alonzo M, Bajaj S, Baker M, Elton E, Farrell TA, Gore RM, Hall C, Nowak J, Roy H, Shaikh A, Talamonti MS (2012). Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: diagnosis-clinical staging and pathology. [Review]. J Surg Oncol, 106, (3), 332-8.
  11. Marsh Rde W, Alonzo M, Bajaj S, Baker M, Elton E, Farrell TA, Gore RM, Hall C, Nowak J, Roy H, Shaikh A, Talamonti MS (2012). Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part II: multidisciplinary management. [Review]. J Surg Oncol, 106, (3), 339-45.
  12. Abbott DE, Baker MS, Talamonti MS (2010). Neoadjuvant therapy for pancreatic cancer: a current review. [Review]. J Surg Oncol, 101, (4), 315-20.

Letter

  1. Kantor O, Baker MS (2018). Response to "Extrapolation of Fistula Grade from the Pancreatectomy Participant Use File of the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP)". [Letter to the editor]. Surgery, 164(5), 1126-1134.
  2. Baker MS, Sharpe SM, Talamonti MS, Wang E, Roggin KK, Bentrem DJ, Winchester DJ, Marsh RD, Stocker SJ (2016). The Learning Curve Is Surmountable: In Reply to Fong and colleagues. [Letter to the editor]. J Am Coll Surg, 222(2), 210-1.